Career guide · Updated June 2026

Medical Science Liaison salary guide: MSL & Medical Advisor pay in 2026

What does a Medical Science Liaison earn? This guide breaks down typical MSL and Medical Advisor base salaries across the EU, UK, and US, how therapeutic area changes the number, and how to use that data when you're negotiating an offer. Ranges below reflect base salary only — bonus, equity, and car/allowances usually add another 10–25% on top.

Typical MSL base (mid-career)

€95k–€125k

Highest-paying region

United States

Top-paying therapeutic areas

Oncology · Rare disease

MSL and Medical Advisor base salary ranges

Ranges are indicative annual base salaries for full-time roles at established pharma and biotech companies. Smaller biotechs may pay below the EU/UK range but compensate with equity; large-cap pharma typically sits in the middle to upper end.

RoleEUUKUS
Entry-level MSL (0–2 yrs)€70k–€95k£60k–£80k$130k–$160k
Mid-level MSL (3–6 yrs)€95k–€125k£80k–£105k$160k–$195k
Senior MSL (7+ yrs)€125k–€160k£105k–£135k$195k–$235k
MSL Manager / Lead€140k–€185k£120k–£160k$220k–$280k
Medical Advisor€85k–€120k£70k–£100k$150k–$190k
Senior Medical Advisor€115k–€150k£95k–£130k$185k–$230k
Medical Affairs Manager€135k–€175k£115k–£150k$210k–$265k

How therapeutic area changes MSL salary

Therapeutic area is one of the biggest drivers of pay variation inside the same job title. Specialist scientific depth — particularly in oncology, rare disease, and cell & gene therapy — consistently commands a premium over the base ranges above.

Oncology
+10% to +20% vs. base range
Highest demand across all regions; rare-disease oncology often pays at the top of the range.
Rare disease / Cell & gene therapy
+10% to +25% vs. base range
Specialist scientific knowledge commands a premium; bonus and equity often larger.
Immunology / Inflammation
+5% to +12% vs. base range
Steady demand, strong launch pipelines.
Neurology
0% to +8% vs. base range
Variable — premium concentrated in CNS and neurodegeneration.
Cardiometabolic
0% to +5% vs. base range
Large therapy area, broader talent pool, smaller premium.
Vaccines / Infectious disease
0% to +10% vs. base range
Premium spikes around launch cycles and outbreak response.

What else affects your MSL offer

  • Bonus. 12–20% target for MSLs and Medical Advisors, 20–30% at Manager/Lead level.
  • Equity / LTI. Standard at biotech, increasingly common at large-cap pharma for senior MSLs.
  • Field allowances. Car or car allowance, home-office setup, and travel per diem are usually on top of base.
  • Territory. National or multi-country roles pay more than single-region territories.
  • Launch readiness. MSLs joining pre-launch teams in oncology or rare disease often negotiate a sign-on bonus.

How to use these numbers in a negotiation

  1. Anchor your ask to the upper third of the range for your region, therapeutic area, and seniority.
  2. Quantify the value you bring — launches supported, KOL relationships, publications, advisory boards.
  3. Negotiate total package (base + bonus + equity + sign-on), not just base.
  4. If base is capped, push on sign-on bonus, accelerated review, or additional vacation.

Get your personal MSL salary benchmark

The ranges above are a starting point. PharmaReady's interactive Salary Benchmark tool uses your specific therapeutic area, region, seniority, and target company to give you a realistic offer range and a negotiation script — included with the Career Accelerator plan.

Disclaimer: salary ranges are estimates based on aggregated Medical Affairs market data as of June 2026 and vary by company, candidate profile, and negotiation. Use as a directional benchmark, not a guarantee.